Louisiana’s 340B contract pharmacy access law is constitutional because it governs drug distribution and not pricing, a state official and [...] …
Year: 2024
A federal judge denied health insurer Humana’s request to dismiss an Alabama health system’s suit against its Medicare Advantage plans [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
One-fifth of 340B hospitals will garner no repayment from Medicare for past underpayments, according to a recent analysis by a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Cosette Pharmaceuticals recently announced refunds to 340B covered entities for 38 medications sold over a year and half. The refunds [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Kansas Gov. Laura Kelly (D) signed a sweeping state budget bill late Wednesday that contains a provision to prohibit drugmaker [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Senate Minority Whip John Thune (R-S.D.) said bipartisan legislation to overhaul the 340B program could be introduced as soon as [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturer Bausch Health announced it will exempt all Arkansas providers and pharmacies from its 340B contract pharmacy policy, including [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
As part of a report on incentivizing use of accountable care organizations (ACOs), Congress’ primary research arm recently recommended excluding [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A small business lobbying organization, created as a more conservative alternative to the U.S. Chamber of Commerce, this week launched [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Japanese drugmaker Takeda recently announced refunds to 340B covered entities for 28 drugs, including one of its top-selling attention-deficit medications. [...] …
